This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License . Your use of this material constitutes acceptance of that license and the conditions of use of materials on this site.
Copyright 2012, The Johns Hopkins University and James D. Yager. All rights reserved. Use of these materials permitted only in accordance with license rights granted. Materials provided “AS IS”; no representations or warranties provided. User assumes all responsibility for use, and all liability related thereto, and must independently review all materials for accuracy and efficacy. May contain materials owned by others. User is responsible for obtaining permissions for use from third parties as needed.
Single Genes and Susceptibility Genes—and Cancer Risk
Definition
Example
Gene prevalence
Gene type
Study setting
Strength of association
Absolute risk
Population attributable risk
Gene-environment interaction/exposure
Single genes
Necessary and sufficient for disease causation
BRCA
APC
RB
(breast/ovary)
(polyposis coli)
(retinoblastoma)
Low
Susceptibility genes
Alter risk—but is neither necessary or sufficient for disease causation
CYP1A1 (lung)
CYP2D6 (lung)
GST-M1 (lung, bladder)
DNA repair genes
Often high
Mutation
Family
Mutation
General population/ epidemiological studies
Low to moderate Very high
High Low
Low High (because mutation common)
Secondary and variable Primary and crucial
39
Gain of function :
–
Proto-oncogenes become oncogenes
•
Point mutation – change in amino acid sequence
•
Translocation – gene or part of gene moved to another location
•
Amplification – multiple copies of gene created
Loss of Function
–
Tumor suppressor genes lose function
•
Deletion
•
Translocation
•
Mutation
40
Presence of proto-oncogenes in normal cells
Detection of activated protooncogenes (oncogenes) in tumor cells
– Ras gene – one of the first discovered using transfection
41
Oncogenes Genes
Selected Examples with Function & Location
Contribute to tumor formation when expression/function enhanced
Genes
Src ras
Selected Examples*
Functions
Cytoplasmic Tyrosine Kinase
G-protein; Signal transduction
rasH
rasK
rasN
Associated Cancers
Sarcomas
Bladder
Lung, Ovarian, Bladder
Breast
Myc
EGF Family
Erb-2/
Her2/neu
Cell Proliferation and DNA Synthesis
mycN
mycC
Membrane Receptor the stimulates DNA
Synthesis – a Tyrosine Kinase
Neuroblastoma, Retinoblastoma
Breast, leukemia, Lung, Cervical, Colon
Breast, Salivary Gland, Ovarian
*Adapted from Cancer Quest – Tumor Suppressors,
Emory University, 2008; accessed Aug, 2011
42
Muller, W. et al. Cell 49: 465-475, 1987
43
erB2/neu
44
Suppressor Genes
Selected Examples with Function & Location
Contribute to tumor formation when expression/function lost or inactivated
Tumor Suppressor genes – Selected Examples
Genes Functions
P53 - Transcription factor regulating genes
Associated Cancers
Bladder, Breast, Liver,
Colorectal, Lung, Prostate controlling cell division and cell death
- Sensor of DNA damage
- Aids in decision between repair and activation
of programmed cell death
Rb - Signal integrator related to cell cycle progression Retinoblastoma, Sarcomas,
- Transduces growth inhibitory signals Bladder, Breast, Lung
BRCA - Involvement in DNA repair
- Regulation of gene expression
Inherited Breast and Ovarian
APC - Controls activity of certain transcription
factors
Familial adenomatous & non-
inherited colorectal cancers
Adapted from Cancer Quest – Tumor Suppressors, Emory University, 2008; accessed Aug, 2011 45
Slide 8 (split)
Genetic Model for
Colorectal Tumorigenesis
50
Whole Exome Sequences of 100 Human Cancers*
SKCCC
11 colorectal cancers
11 breast cancers
24 pancreas cancers
22 gliomas
22 meduloblastomas
Washington
University
2 leukemias
1 breast cancer
British Columbia 1 breast cancer
Cancer Research 4 granulosa cell tumors
Centre
Sanger Institute
1 lung cancer Sanger
1 melanoma
3142 mutated genes
286 tumor suppressors
33 oncogenes
*Vogelstein B AACR Annual Meeting (2010) – Slide provided by W. Nelson
Inherited genetic susceptibility can increase risk
–
Mutations in key genes can lead to high individual risk, but low attributable population risk
– Mutations in certain genes lead to lower individual risk but high attributable population risk
Oncogenes and tumor suppressor genes are key molecular/biological targets
Tumors contain hundreds of mutations and contain a few common mutations
56
Mutations accumulate as as progression occurs
Different carcinogens cause different mutations –
“ finger print ”
–
Adducts of chemicals with DNA bases can serve a biomarkers of biologically effective dose
57